These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7779151

  • 1. [Immunoactive effects of various mistletoe lectin-1 dosages in mammary carcinoma patients].
    Beuth J, Stoffel B, Ko HL, Buss G, Tunggal L, Pulverer G.
    Arzneimittelforschung; 1995 Apr; 45(4):505-7. PubMed ID: 7779151
    [Abstract] [Full Text] [Related]

  • 2. [Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract].
    Beuth J, Ko HL, Tunggal L, Geisel J, Pulverer G.
    Arzneimittelforschung; 1993 Feb; 43(2):166-9. PubMed ID: 7681287
    [Abstract] [Full Text] [Related]

  • 3. Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract.
    Heiny BM, Albrecht V, Beuth J.
    Anticancer Res; 1998 Feb; 18(1B):583-6. PubMed ID: 9568181
    [Abstract] [Full Text] [Related]

  • 4. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients.
    Heiny BM, Beuth J.
    Anticancer Res; 1994 Feb; 14(3B):1339-42. PubMed ID: 8067703
    [Abstract] [Full Text] [Related]

  • 5. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1.
    Beuth J, Ko HL, Tunggal L, Steuer MK, Geisel J, Jeljaszewicz J, Pulverer G.
    In Vivo; 1993 Feb; 7(5):407-10. PubMed ID: 8110981
    [Abstract] [Full Text] [Related]

  • 6. [Immunoactive action of mistletoe lectin-1 in relation to dose].
    Beuth J, Ko HL, Tunggal L, Buss G, Jeljaszewicz J, Steuer MK, Pulverer G.
    Arzneimittelforschung; 1994 Nov; 44(11):1255-8. PubMed ID: 7848341
    [Abstract] [Full Text] [Related]

  • 7. Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice.
    Beuth J, Ko HL, Tunggal L, Buss G, Jeljaszewicz J, Steuer MK, Pulverer G.
    In Vivo; 1994 Nov; 8(6):989-92. PubMed ID: 7772751
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cellular immunomodulation and safety of standardized aqueous mistletoe extract PS76A2 in tumor patients treated for 48 weeks.
    Dohmen W, Breier M, Mengs U.
    Anticancer Res; 2004 Nov; 24(2C):1231-7. PubMed ID: 15154652
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of mistletoe lectin therapy on serum level of defined serum proteins (acute phase proteins) in tumor patients].
    Beuth J, Gabius HJ, Steuer MK, Geisel J, Steuer M, Ko HL, Pulverer G.
    Med Klin (Munich); 1993 May 15; 88(5):287-90. PubMed ID: 7687001
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
    Bocci V.
    J Biol Regul Homeost Agents; 1993 May 15; 7(1):1-6. PubMed ID: 8346712
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.
    Huber R, Lüdtke R, Klassen M, Müller-Buscher G, Wolff-Vorbeck G, Scheer R.
    Eur J Med Res; 2001 Sep 28; 6(9):399-405. PubMed ID: 11669085
    [Abstract] [Full Text] [Related]

  • 20. [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks].
    Gabius S, Gabius HJ.
    Dtsch Med Wochenschr; 2002 Mar 01; 127(9):457-9. PubMed ID: 11870561
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.